PRA Health Sciences Inc

PRA Health Sciences — Q1 2016 Earnings Presentation

16 slides from PRA Health Sciences's earnings presentation, Apr 27, 2016

  1. Slide 1: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  2. Slide 2: Q1 2016 Highlights

    Q1 2016 Highlights ($ in millions, except per share amounts) • $372.3 million of service revenue; 13.0% constant currency growth • $67.4 million of Adjusted EBITDA; 20.8% growth compared to prior year • Adjusted Net Income per diluted share of $0.55; 34.1% growth compared to prior year Q1 2016 Q1 20

  3. Slide 3: Trailing Quarterly Performance

    Trailing Quarterly Performance Adjusted Income from Operations ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $33.7 $40.6 $41.0 $45.2 $50.6 $56.2 $61.2 $62.4 $61.7 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 12.7% 14.6% 14.7% 15.6% 16.8% 18.2% 1

  4. Slide 4: Backlog and New Business Awards

    Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.13 1.19 1.19 1.20 1.20 1.21 1.25 1.27 1.28 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 $351.3 $371.9 $382.1 $388.4 $398.0 $407.8 $431.4 $459.4 $476.2 Q

  5. Slide 5: Debt Structure

    Debt Structure Weighted Average ($ in millions) March 31, June 30, September 30, December 31, March 31, Interest Maturity 2015 2015 2015 2015 2016 Rate Date Senior debt: First Lien 714.0 $ 699.0 $ 689.0 $ 689.0 $ 689.0 $ 4.50% September 23, 2020 Senior Notes 225.0 225.0 225.0 225.0 91.4 9.50% Octobe

  6. Slide 6: 2016 Guidance Update

    2016 Guidance Update Original Guidance (Feb 24, 2016) Revised Guidance (April 27, 2016) Service Revenue, in Millions $1,530.0 – $1,570.0 $1,530.0 – $1,570.0 GAAP Earnings per Diluted Share $1.56 – $1.66 $1.08 – $1.15 Adjusted Net Income per Diluted Share $2.32 – $2.42 $2.41 – $2.48 Annual Effective

  7. Slide 7: 2016 Guidance Update

    xe | 2016 Guidance Update Revised Guidance Guidance (Feb 24,2016) (April 27, 2016) $1,530.0 — $1,530.0 — $1,570.0 $1,570.0 Service Revenue, in Millions GAAP Earnings per Diluted Share $1.56 — $1.66 $1.08 - $1.15 Adjusted Net Income per Diluted Share $2.32 - $2.42 $2.41 - $2.48 Annual Effective Incom

  8. Slide 8: Trailing Quarterly Performance

    Trailing Quarterly Performance Q1 16 v ($ in millions) Q1 15 2016 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Change Service revenue 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 336.5 $ 345.1 $ 362.3 $ 1,375.8 $ 372.3 $ 12.2% % growth Y-o-Y 87.0% 73.4% 70.2% 8.4% 52.1% 6.6% 8.1% 7.8% 11.9% 8.6% 12.2% %

  9. Slide 9: Backlog and New Business Awards

    Backlog and New Business Awards Q1 16 v ($ in millions) Q1 15 2016 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Change Beginning Backlog 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ 2,185.3 $ 2,262.4 $ 2,348.4 $ 2,141.1 $ 2,440.1 $ Ending Backlog 1,987.3 $ 2,044.8 $ 2,091.5 $ 2,141.1 $ 2,141.1

  10. Slide 10: Reconciliation of GAAP EBITDA to Adjusted EBITDA

    Reconciliation of GAAP EBITDA to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 Net (loss) income (16.0) $ 17.2 $ Depreciation and amortization 17.0 19.2 Interest

  11. Slide 11: Reconciliation of GAAP Net (Loss) Income to Adjusted Net Income

    Reconciliation of GAAP Net (Loss) Income to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2016 2015 Net (loss) income (16.0) $ 17.2 $ Amortizatio

  12. Slide 12: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 Income from operations 18.9 $ 32.9 $ Amortization o

  13. Slide 13: Geographic Breakdown

    Geographic Breakdown ($ in millions) Region Q1 16 Q1 15 US/Canada 225.4 202.0 Europe/Africa 114.9 101.0 Latin America 13.9 13.4 Asia/Pacific 18.1 15.5 Grand Total 372.3 332.0

  14. Slide 14: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) 2016 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Accounts Receivable, net $ 246.0 $ 241.9 $ 236.1 $ 233.3 $ 239.6 $ 281.4 $ 281.9 $ 288.3 $ 285.7 Unbilled Services 102.3 98.0 113.2 105.5 132.8 115.2 118.5 126.8 134.4 Total Accounts Receivable and Unbilled Services 348.3 339.9 3

  15. Slide 15: Days Sales Outstanding

    | Days Sales Outstanding (Sinmiions) ‘Accounts Receivable, net Unbilled Services Total Accounts Receivable and Unbilled Services ‘Advanced Bilings Net Accounts Receivable, net Unbilled Services Total Accounts Receivable and Unbilled Services ‘Advanced Billings Net 2018 2015 2016 a cy 3 a a a ce aa a

  16. Slide 16: PRA Health Sciences

    m\/A Ws PRAHEALTHSCIENCES HE FU RE OF CLINICAL DEVELOPME

PRA Health Sciences — Q1 2016 Earnings Presentation on 6ix